MoneyWorks4Me

Cipla submits press release

22 Jul 2019 Evaluate

Cipla has informed about submission of press release dated 22nd July, 2019 regarding its wholly owned step down subsidiary lnvaGen Pharmaceuticals Inc. receives final approval for generic version of Pfizer's Lyrica (Pregabalin Capsules, 25mg, 50mg, 75mg, 100 mg, 150mg, 200mg, 225mg, 300mg). 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..